Respir Res 2023 Jan 9
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Related Questions
Patients on baseline mycophenolate and azathioprine were excluded from the INBUILD trial however many patients with CTD-ILD will be on some form of im...
New answer by at Cleveland Clinic (July 18, 2023)
If you look at Figure 4B in this Delphi consensus paper on treating patients with SSc-ILD, the consensus of expert pulmonologists/rheumatologists is to "add on" additional the...